+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

Hospital Acquired Candida Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Hospital Acquired Candida Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Multidrug Resistant Acinetobacter Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Multidrug Resistant Acinetobacter Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Rhinovirus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Rhinovirus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Shigella Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Shigella Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Schistosomiasis - Pipeline Insight, 2025 - Product Thumbnail Image

Schistosomiasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
West Nile - Pipeline Insight, 2025 - Product Thumbnail Image

West Nile - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
HSV-1 Keratitis - Competitive landscape, 2024 - Product Thumbnail Image

HSV-1 Keratitis - Competitive landscape, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
From
From
From
Hospital Infection Therapeutics Market 2024-2028 - Product Thumbnail Image

Hospital Infection Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 184 Pages
  • Global
From
Surgical Site Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Surgical Site Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more